{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:40:46Z","timestamp":1790462446808,"version":"4.1.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0006442","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T00:00:00Z","timestamp":1525824000000}}],"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T00:00:00Z","timestamp":1524787200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1112376"],"award-info":[{"award-number":["OPP1112376"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0006442","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T17:35:23Z","timestamp":1524850523000},"page":"e0006442","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Impact of lower challenge doses of enterotoxigenic Escherichia coli on clinical outcome, intestinal colonization and immune responses in adult volunteers"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6446-0255","authenticated-orcid":true,"given":"Subhra","family":"Chakraborty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clayton","family":"Harro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"DeNearing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Brubaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Len","family":"Dally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Louis","family":"Bourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Sack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,4,27]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/CMR.18.3.465-483.2005","article-title":"Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention","volume":"18","author":"F Qadri","year":"2005","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1586\/erv.12.37","article-title":"Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans","volume":"11","author":"W Zhang","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"9888","key":"ref3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","article-title":"Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study","volume":"382","author":"KL Kotloff","year":"2013","journal-title":"Lancet"},{"issue":"10051","key":"ref4","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0140-6736(16)31529-X","article-title":"Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study","volume":"388","author":"J Liu","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"e2705","DOI":"10.1371\/journal.pntd.0002705","article-title":"Estimating diarrheal illness and deaths attributable to Shigellae and enterotoxigenic Escherichia coli among older children, adolescents, and adults in South Asia and Africa","volume":"8","author":"LM Lamberti","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"ref6","doi-asserted-by":"crossref","first-page":"e564","DOI":"10.1016\/S2214-109X(15)00151-5","article-title":"Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED)","volume":"3","author":"JA Platts-Mills","year":"2015","journal-title":"Lancet Glob Health"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/INF.0000000000000351","article-title":"Effects of Shigella-, Campylobacter- and ETEC-associated diarrhea on childhood growth","volume":"33","author":"G Lee","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1128\/CVI.00617-15","article-title":"Characterization of Mucosal Immune Responses to Enterotoxigenic Escherichia coli Vaccine Antigens in a Human Challenge Model: Response Profiles after Primary Infection and Homologous Rechallenge with Strain H10407","volume":"23","author":"S Chakraborty","year":"2015","journal-title":"Clin Vaccine Immunol"},{"issue":"26","key":"ref9","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1016\/j.vaccine.2016.02.076","article-title":"Status of vaccine research and development for enterotoxigenic Escherichia coli","volume":"34","author":"AL Bourgeois","year":"2016","journal-title":"Vaccine"},{"issue":"35","key":"ref10","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.1016\/j.vaccine.2011.05.021","article-title":"A systematic review of experimental infections with enterotoxigenic Escherichia coli (ETEC)","volume":"29","author":"CK Porter","year":"2011","journal-title":"Vaccine"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.vaccine.2014.11.049","article-title":"An assessment of enterotoxigenic Escherichia coli and Shigella vaccine candidates for infants and children","volume":"33","author":"RI Walker","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1128\/IAI.17.1.78-82.1977","article-title":"Diarrhea caused by Escherichia coli that produce only heat-stable enterotoxin","volume":"17","author":"MM Levine","year":"1977","journal-title":"Infect Immun"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/oxfordjournals.aje.a112906","article-title":"Lack of person-to-person transmission of enterotoxigenic Escherichia coli despite close contact","volume":"111","author":"MM Levine","year":"1980","journal-title":"Am J Epidemiol"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1128\/IAI.66.5.1968-1972.1998","article-title":"Validation of a volunteer model of cholera with frozen bacteria as the challenge","volume":"66","author":"DA Sack","year":"1998","journal-title":"Infect Immun"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1128\/IAI.70.4.1965-1970.2002","article-title":"Randomized, controlled human challenge study of the safety, immunogenicity, and protective efficacy of a single dose of Peru-15, a live attenuated oral cholera vaccine","volume":"70","author":"MB Cohen","year":"2002","journal-title":"Infect Immun"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1086\/644622","article-title":"Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects","volume":"49","author":"DR Tribble","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1128\/CVI.05194-11","article-title":"Refinement of a human challenge model for evaluation of enterotoxigenic Escherichia coli vaccines","volume":"18","author":"C Harro","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/1574-6968.12362","article-title":"Quantitative PCR and culture evaluation for enterotoxigenic Escherichia coli (ETEC) associated diarrhea in volunteers","volume":"352","author":"BR Lindsay","year":"2014","journal-title":"FEMS Microbiol Lett"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1128\/CVI.00608-15","article-title":"Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects","volume":"23","author":"S Chakraborty","year":"2016","journal-title":"Clin Vaccine Immunol"},{"issue":"12","key":"ref20","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1128\/CVI.00364-12","article-title":"The oral, live attenuated enterotoxigenic Escherichia coli vaccine ACE527 reduces the incidence and severity of diarrhea in a human challenge model of diarrheal disease","volume":"19","author":"MJ Darsley","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1128\/CVI.05342-11","article-title":"A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phase I trial in healthy adults","volume":"18","author":"C Harro","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"30","key":"ref22","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1016\/j.vaccine.2013.04.066","article-title":"Different kinetics of circulating antibody-secreting cell responses after primary and booster oral immunizations: a tool for assessing immunological memory","volume":"31","author":"S Leach","year":"2013","journal-title":"Vaccine"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1128\/IAI.19.3.883-888.1978","article-title":"Differences in serological responses and excretion patterns of volunteers challenged with enterotoxigenic Escherichia coli with and without the colonization factor antigen","volume":"19","author":"DG Evans","year":"1978","journal-title":"Infect Immun"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ebiom.2016.07.030","article-title":"Environmental Enteropathy: Elusive but Significant Subclinical Abnormalities in Developing Countries","volume":"10","author":"K Watanabe","year":"2016","journal-title":"EBioMedicine"},{"issue":"8","key":"ref25","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3855\/jidc.6460","article-title":"Application of Luminex Gastrointestinal Pathogen Panel to human stool samples from Cote d'Ivoire","volume":"9","author":"V Di Cristanziano","year":"2015","journal-title":"J Infect Dev Ctries"},{"issue":"9","key":"ref26","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/infdis\/jiv593","article-title":"Transcriptomic Analysis of the Host Response and Innate Resilience to Enterotoxigenic Escherichia coli Infection in Humans","volume":"213","author":"WE Yang","year":"2016","journal-title":"J Infect Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1186\/s12864-016-2777-0","article-title":"Individual-specific changes in the human gut microbiota after challenge with enterotoxigenic Escherichia coli and subsequent ciprofloxacin treatment","volume":"17","author":"M Pop","year":"2016","journal-title":"BMC Genomics"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0006442","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T00:00:00Z","timestamp":1525824000000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0006442","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T10:11:31Z","timestamp":1604225491000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0006442"}},"subtitle":[],"editor":[{"given":"Stephen","family":"Baker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,27]]},"references-count":27,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0006442","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0006442","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,27]]}}}